SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > UTI Mutual Fund > UTI Pharma & Healthcare Fund (G)

UTI Pharma & Healthcare Fund (G) SET SMS ALERT

71.697
1.06 (1.50%)
NAV as on Jul-30-2014
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Mar 2014) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on Jul-30-2014)

Period Returns (%) Rank #
1 mth 7.6 4
3 mth 14.0 4
6 mth 21.0 4
1 year 37.1 6
2 year 28.7 3
3 year 19.6 2
5 year 25.7 3

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2014 0.9 12.6 - - -
2013 -4.1 10.0 5.5 8.3 23.0
2012 6.9 2.3 8.0 4.9 25.0
2011 -7.8 6.1 -7.2 -0.7 -10.0
2010 11.8 8.9 1.4 9.9 37.4
2009 -1.3 18.2 25.1 -0.2 65.7

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 7.6 14.0 21.0 37.1 28.7 19.6 25.7
Category avg 6.6 14.4 22.4 42.9 15.6 11.1 13.8
Difference of Fund returns and Category returns 1.0 -0.4 -1.4 -5.8 13.1 8.5 11.9
Best of category 8.0 17.2 25.8 46.9 36.0 27.3 28.8
Worst of category 4.2 11.8 20.2 37.1 28.7 19.6 25.7
Benchmark returns # 9.4 15.3 21.6 32.4 31.8 24.1 --
Difference of Fund returns and Benchmark returns -1.8 -1.3 -0.6 4.7 -3.1 -4.5 25.7
# Benchmark Index: CNX Pharma

Investment Info

Investment Objective

Investment will be made in stocks of companies engaged in manufacturing of Pharmaceuticals bulk drugs, formulations & OTC drugs, medical equipment and accessories, personal healthcare products and also companies owning/managing hospitals etc.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jun 26, 1999
Benchmark CNX Pharma
Asset Size (Rs cr) 149.44 (Jun-30-2014)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Lalit Nambiar
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if redeemed within 1 Year from the date of allotment.

Contact Details

Regd. Office UTI Tower, Gn Block, Bandra-Kurla Complex, Bandra (E), Mumbai, 400051
Tel. No. 66786666
Fax No. 26524921
Email uti@giasbm01.vsnl.net.in
Website http://www.utimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
773.24 11.8 20.2 44.2 19.6 28.8
SBI Pharma Fund (G) Not Ranked
194.91 17.0 25.3 45.7 27.3 28.4
UTI Pharma & Health (G) Not Ranked
149.44 14.0 21.0 37.1 19.6 25.7
Reliance Pharma Fund - Direct (G) Not Ranked
36.13 12.0 20.6 45.2 -- --
SBI Pharma Fund - Direct (G) Not Ranked
21.33 17.2 25.8 46.9 -- --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Jun 30, 14)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 33.86 22.66
Dr Reddys Labs Pharmaceuticals 23.06 15.43
Lupin Pharmaceuticals 17.05 11.41
Cipla Pharmaceuticals 13.72 9.18
Divis Labs Pharmaceuticals 7.49 5.01
Biocon Pharmaceuticals 6.08 4.07
Ranbaxy Labs Pharmaceuticals 5.44 3.64
Cadila Health Pharmaceuticals 4.51 3.02
Aurobindo Pharm Pharmaceuticals 4.21 2.82
Wyeth Pharmaceuticals 3.62 2.42

Full Portfolio

Sector Allocation (Jun 30, 14)

Sector %

1-Year

HighLow

Pharmaceuticals 97.52 97.82 88.35

View All Sectors

Asset Allocation (%)(Jun 30, 14)

Equity 97.52
Others 0.00
Debt 0.08
Mutual Funds N.A
Money Market 0.00
Cash / Call 2.40

View All

Concentration

Holdings (%)
Top 5 63.69
Top 10 79.66
Sector (%)
Top 3 97.52

News & Videos

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.